Blog

Q&A with a clinical research site discussing COVID-19 and the movement towards Direct-to-Patient trials.

Direct-to-Patient (DtP) trials are more prevalent than ever before. Here are 5 questions to ask yourself when planning a DtP trial.

In this interview, two senior industry clinical trial supply professionals discuss experiences with manual tools and existing commercial solutions, as well as the need for an improved clinical supply forecasting solution.

Integrations don't need to involve complicated coding to develop. Modern tech can simplify implementation and enable a conversation between systems.

Excel is a great tool for planning. It's easy to use and for experienced users provides insight into data. But is it the best choice for your trial?

CSPs should be empowered with a good level of understanding what variables or information is critical to model supply planning (feasibility planning to study planning) so they can react and make decisions more effectively.

Over the life of a study, the amount of time and resources spent on changes to a system can significantly impact the study – but do they have to?

Did you know that Phase 1 trials can be even more complex than their Phase 2 and 3 counterparts? Don't let scale be the determining factor in choosing to leverage an RTSM. Here are 5 questions to ask when you consider an RTSM for your next Phase 1 study.

Having an IRT/RTSM for your IITs will help with supply chain management since IITs traditionally draw from the same pool of drugs as manufacturer-sponsored studies. See how.